News

There is a little-known conflict in the world today that is escalating and could quickly get out of hand. While governments and nations used to fight over commodities or trade routes, today's

The defensive names, characterized by their immunity to the business cycle, in the market could soon see an inflow of investment dollars not seen since the last wave of the business cycle. This

The Dow Jones Industrial Average of blue chip stocks is trading higher for the week, but is still in correction territory, having posted losses in each of the past three months.

However, it’s a

Chipotle Mexican Grill Inc. (NYSE: CMG), Visa Inc. (NYSE: V) and Stryker Corp. (NYSE: SYK) may not, at first glance, seem like they have much in common. However, they’re part of an elite group: All

Shares of Microsoft Corp. (NASDAQ: MSFT) declined 1.92% on June 26, more than the broader market, while Activision Blizzard Inc. (NASDAQ: ATVI) rose 1.83%. The S&P 500 declined 0.41% in the session

Markets closed the week in a state of cautious optimism. The S&P 500 is officially out of bear market territory but, in the words of another Fed chairman, this is no time for “irrational

Two competing stories are fighting for investors’ attention. The bulls are trying to push the market higher in expectations of a resolution to the debt ceiling standoff. But any excitement is being

Some like it hot. That’s what some investors said to the April jobs report which came in hotter than expected. Recently, a strong jobs number would be interpreted as bad news for equity markets, but

Markets continue to look for direction between earnings reports and new economic data. This week, investors received strong earnings reports from tech giants such as Microsoft and Meta Platforms

On’s (NYSE: ONON) Q1 results prove it is gaining traction with athletes and is on track to dethrone Nike (NYSE: NKE) as the god of running shoes. The company’s results exceeded expectations on

Over the past year, technology stocks have received the lion’s share of market attention and performance. Not all stocks in the space are equal, though; investors made it abundantly clear that

When investors think about their potential winnings through the stock market, two methods typically get the lion’s share of attention. The most straightforward appreciation will happen through the

Biopharma giant Pfizer Inc. (NYSE: PFE) has given back all its COVID gains and more. Shareholders have sat through a painful two-year selloff from the stock's $61.71 high on December 20, 2021, to